Australia TGA ARTG recordHaematological concentrate system kit, platelet concentration
Australia TGA ARTG Registered Device · Surgical Specialties Pty Ltd · Ranfac Corporation · Class IIa · Started August 25, 2023
Good Name: Surgical Specialties Pty Ltd - Haematological concentrate system kit, platelet concentration
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- August 25, 2023
- Effective Date
- August 25, 2023
- Country
- United States of America
- Address
- 30 Doherty Avenue, AVON, MA, 02322
The Cervos Platelet Separator system is designed to be used for the safe and rapid preparation of autologous platelet rich plasma (PRP) from a small sample of peripheral blood for mixing with autograft and/or allograft bone prior to application to a bony defect to improve handling characteristics.
Access comprehensive regulatory information for Haematological concentrate system kit, platelet concentration in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Surgical Specialties Pty Ltd, manufactured by Ranfac Corporation in United States of America. The device registration started on August 25, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.